Skip to main content
. 2024 Mar 21;45(18):1647–1658. doi: 10.1093/eurheartj/ehae100

Figure 2.

Figure 2

Kidney function is improved at 3 months in patients receiving inorganic nitrate. Panel A shows the change in serum creatinine concentration at 3 months from baseline with a significant decrease in the inorganic nitrate group compared to the placebo group (−10.42 (95% confidence interval: −14.98 to −5.86), P < .001; difference as estimated by linear regression adjusting for baseline creatinine and diabetes status). Panel B shows the change in eGFR concentration at 3 months from baseline with a significant increase in the inorganic nitrate group compared to the placebo group (5.17 (95% confidence interval 2.94–7.39), P < .001; difference as estimated by linear regression adjusting for baseline creatinine and diabetes status)